Breast Augmentation Toronto – Cosmetic Surgery Institute

Macrolane Registry

Q-Med is currently developing a registry in the UK to monitor their product Macrolane, a hyaluronic acid filler product that was approved in the country last year as a form of nonsurgical breast augmentation. Even though Macrolane has already been approved by the government, the registry is being set up as a commitment to the safety and welfare of patients and consumers. The results of treatments and trends will be included to ensure the safety and effectiveness of the product.

Q-Med is also conducting further research to not only improve technique, but also to examine how it holds up to other methods of breast augmentation. For example, a study currently underway compares the results achieved through fat transfer and Macrolane in patients undergoing breast reconstruction.

Macrolane was approved in the UK and the EU in 2008. It has not been approved by Health Canada or the FDA for breast augmentation and has received somewhat mixed reviews in the media. An estimated 3,000 procedures across Europe have been performed up to this date, only by physicians certified by Q-Med.

The Swedish biotechonlogy company Q-Med first gained fame for creating NASHA (stabilised non-animal hyaluronic acid), a vital component of such popular fillers as Juvederm and Restylane. Their innovative product, Macrolane, can also be used for other body contouring procedures, such as augmentation of the buttocks and calves.

• Posted in Alternative Methods
• 1 Comment